The Anti-Sigma Factor MucA of Pseudomonas aeruginosa: Dramatic Differences of a mucA22 vs. a ΔmucA Mutant in Anaerobic Acidified Nitrite Sensitivity of Planktonic and Biofilm Bacteria in vitro and During Chronic Murine Lung Infection by Panmanee, Warunya et al.
RESEARCH ARTICLE
The anti-sigma factor MucA of Pseudomonas
aeruginosa: Dramatic differences of a mucA22
vs. a ΔmucA mutant in anaerobic acidified
nitrite sensitivity of planktonic and biofilm
bacteria in vitro and during chronic murine
lung infection
Warunya Panmanee1, Shengchang Su1, Michael J. SchurrID2, Gee W. Lau3, Xiaoting Zhu4,
Zhaowei Ren4, Cameron T. McDaniel1, Long J. Lu4, Dennis E. Ohman5,6, Daniel
A. Muruve7, Ralph J. Panos8,9, Hongwei D. Yu10, Thomas B. Thompson1, Boo
Shan TsengID11, Daniel J. HassettID1*
1 Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of
Medicine, Cincinnati, OH United States of America, 2 Department of Immunology and Microbiology,
University of Colorado School of Medicine, Aurora, CO United States of America, 3 College of Veterinary
Medicine, University of Illinois at Urbana-Champaign, Urbana, IL United States of America, 4 Division of
Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH United States of
America, 5 Department of Microbiology and Immunology, Virginia Commonwealth University Medical Center,
Richmond, VA United States of America, 6 McGuire Veterans Affairs Medical Center, Richmond, VA United
States of America, 7 Department of Medicine, University of Calgary, Calgary, Alberta, Canada, 8 Department
of Medicine, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH United States of America,
9 Pulmonary, Critical Care, and Sleep Division, Department of Medicine, University of Cincinnati College of
Medicine, Cincinnati, OH United States of America, 10 Department of Biochemistry and Microbiology,
Marshall University, Huntington, WV United States of America, 11 Department of Life Sciences, University of
Nevada-Las Vegas, Las Vegas, NV United States of America
* Daniel.Hassett@UC.Edu
Abstract
Mucoid mucA22 Pseudomonas aeruginosa (PA) is an opportunistic lung pathogen of cystic
fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients that is highly sen-
sitive to acidified nitrite (A-NO2-). In this study, we first screened PA mutant strains for sensi-
tivity or resistance to 20 mM A-NO2- under anaerobic conditions that represent the chronic
stages of the aforementioned diseases. Mutants found to be sensitive to A-NO2- included
PA0964 (pmpR, PQS biosynthesis), PA4455 (probable ABC transporter permease), katA
(major catalase, KatA) and rhlR (quorum sensing regulator). In contrast, mutants lacking
PA0450 (a putative phosphate transporter) and PA1505 (moaA2) were A-NO2- resistant.
However, we were puzzled when we discovered that mucA22 mutant bacteria, a frequently
isolated mucA allele in CF and to a lesser extent COPD, were more sensitive to A-NO2- than
a truncated ΔmucA deletion (Δ157–194) mutant in planktonic and biofilm culture, as well as
during a chronic murine lung infection. Subsequent transcriptional profiling of anaerobic, A-
NO2--treated bacteria revealed restoration of near wild-type transcript levels of protective
NO2- and nitric oxide (NO) reductase (nirS and norCB, respectively) in the ΔmucA mutant in
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contrast to extremely low levels in the A-NO2--sensitive mucA22 mutant. Proteins that were
S-nitrosylated by NO derived from A-NO2- reduction in the sensitive mucA22 strain were
those involved in anaerobic respiration (NirQ, NirS), pyruvate fermentation (UspK), global
gene regulation (Vfr), the TCA cycle (succinate dehydrogenase, SdhB) and several double
mutants were even more sensitive to A-NO2-. Bioinformatic-based data point to future stud-
ies designed to elucidate potential cellular binding partners for MucA and MucA22. Given
that A-NO2- is a potentially viable treatment strategy to combat PA and other infections, this
study offers novel developments as to how clinicians might better treat problematic PA infec-
tions in COPD and CF airway diseases.
Introduction
Chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) are two chronic air-
way diseases complicated by life-threatening infections caused by the opportunistic Gram-neg-
ative bacterium, Pseudomonas aeruginosa (PA). In the United States alone, there are an
estimated 15 million COPD patients (251 million worldwide (WHO estimates, [1]), while
there are only 30,000 U.S. CF patients (70,000 world-wide, [2]). COPD is a highly deteriorative
alveolar disease coupled with airway derangements causing an accumulation of thick mucus
that is typically a consequence of long-term smoking. Cultures of respiratory secretions yield
PA in 8.5–16.8% of patients who also experience more frequent COPD exacerbations [3, 4]
and up to 18% of patients requiring mechanical ventilation [5] who have increased mortality.
In contrast, CF airway disease is biphasic, involving an early oxidative, neutrophil-rich envi-
ronment [6] (especially during acute exacerbations) [7] followed by a chronic hypoxic or
anaerobic phase [8–10]. In contrast, chronically infected patients suffer from poor airway oxy-
genation resulting, in part, from intractable, antibiotic-resistant [11] bacterial communities
known as biofilms that are formed by PA and other organisms embedded within thick micro-
aerobic [12] or anaerobic airway mucus [8, 13–16].
A further reduction in lung function occurs when mucoid, mucA22 mutant alginate-over-
producing mutant PA forms biofilms that are of the mode II variety [13, 17, 18]. The mucA22
allele results from a C residue deletion at position 430, leaving a truncated 15.8 kDa MucA pro-
tein [19]. Unlike mode I biofilms, where organisms attach directly to animate (e.g., cells) or
inanimate (e.g., plastic, glass, etc.) surfaces, mode II biofilm bacteria are not attached to sur-
faces, but rather to themselves, developing as highly structured communities embedded within
the thick mucus that mature into “soccer ball-shaped” micro- and/or macrocolonies in the
infected airways [20]. Many research groups around the world are attempting to unravel the
precise metabolic features of PA within mode II biofilms embedded within the CF and COPD
airway mucus [17, 21, 22]. Metabolism of certain amino acids appears to be prevalent among
PA isolates from chronically infected patients including aromatic amino acids, specifically phe-
nylalanine and tyrosine [23]. Two seminal papers were published in 2002 by our group (Yoon
et al., [8]) and Worlitzsch et al., [13] that indicate that oxygen tension within the thick mucus
lining of the CF airways is significantly reduced and there are some niches that are likely
completely anaerobic. For many CF and COPD pathogens, including PA, an alternative elec-
tron acceptor such as nitrate (NO3
-) or nitrite (NO2
-) is required. Both NO3
- and NO2
- can be
detected in sufficient quantities for PA to undergo anaerobic respiration in both CF [24] and
COPD [25]. Since our anaerobic biofilm theory of chronic CF lung disease was reported in
2002 [8], obligate anaerobes have been isolated from CF sputum (for recent review, see [18])
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as well as in COPD sputum [26]. In fact, there have been many published manuscripts span-
ning over 40 years describing the isolation of obligate anaerobes from the CF airways, thereby
supporting our anaerobic theory [10, 27, 28] (for mini-reviews, see [17, 18]). In conjunction
with anaerobic nitrogen oxide metabolism, one very significant development in the potential
treatment of mucoid PA was discovered in 2006 where we (Yoon et al., [9]) also showed that
mucoid mucA22 mutant CF isolates were sensitive to acidified sodium nitrite (herein termed
A-NO2
-). A-NO2
- was used in the aforementioned study because we found that the pH of the
CF airway surface liquid from explanted CF lungs was ~6.4–6.5 [9]. However, in that study, of
nearly 100 mucoid PA isolates from 12 different North American CF clinics, expectedly none
possessed true deletions of the mucA gene [9]. A second study, using the other two major
COPD and CF pathogens methicillin-resistant Staphylococcus aureus and Burkholderia cepa-
cia, as well as nonmucoid PA showed that A-NO2- also kills these organisms, particularly
under anaerobic conditions [29]. Relatedly, it should be noted that one feature of CF is
reduced airway iNOS (inducible nitric oxide (NO) synthase) expression, especially in chronic
CF [30]. iNOS is an enzyme that generates potentially antimicrobial levels of nitric oxide (NO)
and is a major contributor to the hosts innate immune system. In contrast, iNOS also appears
to play a role in COPD, as iNOS mRNA levels were recently shown to be elevated in COPD
patient’s relative to nonsmokers and smokers without COPD [31].
There is a severe dearth of nearly any formal understanding of the genetics of adaptive
mutations in PA that are acquired in COPD. Puzzlingly, given the estimated 3,600-fold
reduced patient numbers world-wide for CF relative to COPD, vastly more is understood
regarding mutations that emerge during the course of CF [32, 33]. For example, PA acquires 3
adaptive mutations during CF, lasR (early �x= 12 years, rhlR (�x= 17 years [34]) and mucA
(early [in some cases 3 yrs old] and late (chronic) CF [9, 35] and likely also in COPD [36]. In
2002, we discovered yet another weakness in mutants frequently isolated from CF patient spu-
tum. We discovered that anaerobic PA rhlR QS (controlled by the las system) mutants in PA
anaerobic biofilms mysteriously committed an anaerobic metabolic suicide in biofilms by
overproduction of toxic endogenous levels of respiratory NO [8]. Chronic, long-term infec-
tions are characterized by bacteria that have undergone a process known as mucoid conver-
sion within the progressively thickened airway mucus [37]. This process involves mutations in
a variety of genes including mucB (algN) (periplasmic protein that binds the anti-sigma factor,
MucA, [38, 39]), algW (encoding a membrane protease that cleaves MucA [40]), and mucD (a
periplasmic protease that degrades MucA via activation of MucP [39, 41]. However, the most
abundant mutations that trigger mucoid conversion in both COPD [31, 36] and CF [9, 35] are
within the mucA gene, encoding a cytoplasmic membrane-spanning anti-sigma factor [35].
The primary appreciated function of MucA is to sequester the extracytoplasmic sigma factor
AlgT(U) near the cytoplasmic side of the inner membrane [42]. The most common mucA
mutant allele is called mucA22 [9, 35], caused by a C deletion at base 430, resulting in a 15.8
kDa truncated protein that allows mucoid conversion by enabling AlgT(U) to activate tran-
scription of genes involved in production of the viscous exopolysaccharide alginate, a large lin-
ear β-1,4-linked co-polymer consisting of β-D-mannuronate and α-L-guluronate [43, 44]. The
production of alginate severely complicates the clinical course for CF patients [45], resulting in
progressively worsened forced expiratory volume per second (FEV1) measurements and poor
pulmonary function tests (PFTs). Thus, mucoid conversion is often considered one, if not the
most negative, clinical hallmarks precipitating a dramatic antibiotic regimen adjustment for
patients infected by such organisms.
Given this important and comprehensive background information, in this study, we elected
to first identify a series of transposon mutants that were either more susceptible or resistant to
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defined concentrations of anaerobic A-NO2
-. During this process, we discovered a different
and unexpected role of MucA in sensitivity to A-NO2
- by generating not only mucA22
mutants, but also a truncated ΔmucA mutant (Δ157–194), the latter of which were surprisingly
resistant to A-NO2
- relative to its mucA22 counterpart. We used a combined transcriptional
profiling and protein S-nitrosylation approach to identify potential mechanisms of A-NO2-
sensitivity in wild-type, mucA22 vs. ΔmucA strains. First, the transcription levels of genes
encoding nitrate (NO3
-), nitrite (NO2
-) and nitric oxide (NO) reductase (collectively NAR,
NIR and NOR) were at or near wild-type levels in ΔmucA and wild-type bacteria when com-
pared to the mucA22 mutant, which we show to be far lower in this study upon exposure to
A-NO2
-. Consistent with these observations, we show that mucA22 bacteria are susceptible to
A-NO2
- during a chronic lung infection in mice, while ΔmucA bacteria were resistant. Our
data also involved extensive bioinformatics analysis suggesting that MucA22, a truncated
~15.8 kDa protein, has an as yet unknown anaerobic function, but also confers a significant
defect, a translationally-significant and marked sensitivity to A-NO2
-.
Results
Screening for PA strains that demonstrate enhanced sensitivity or
resistance to A-NO2
-
A mariner Tn library representing a three genome coverage (~15,000 mutants) and previously
constructed insertion or deletion mutants were used to screen for PA strains for sensitivity or
resistance to 20 mM A-NO2
- under anaerobic conditions (Table 1). Using wild-type PAO1
bacteria and strain FRD1 as respective A-NO2
- resistant and sensitive controls, several Tn
mutants that were identified to be more resistant to A-NO2
-. These included PA1504 (tran-
scriptional regulator), PA0450 (probable PO4
3- transporter), PA1370 (hypothetical protein),
and PA0780 (proline utilization regulator). In contrast, A-NO2
- sensitive strains included
mutants lacking PA0964 (pmpR, regulator of PqsR-mediated quorum sensing, [46]), PA4455
(a putative ABC transporter permease [47]), ribonucleotide diphosphate reductase subunits
Table 1. Transposon (Tn) and gene replacement mutants found to be sensitive (S) or resistant (R) to 20 mM
A-NO2
- under anaerobic conditions after 24 hr incubation.
Strain Gene (Sensitive (S)/Resistant (R) Reference
FRD1 mucA22 S [51]
PAO1 mucA22 S [9], This study
PAO1 pmpR::Tn-Gm S This study
PAO1 norCB::Gm S [50]
PAO1 rhlR::Gm S [52]
PAO1 katA::Gm S [53]
PAO1 lon::Tn-Gm S This study
PAO1 nrdJa,b::Tn-Gm S This study
PAO1 nuoK::Tn-Gm S This study
PAO1 PA4455::Gm S [47], This study
PAO1 ΔmucA (Δ157–194) (Hassett lab) S This study
PAO1 ΔmucA (Δ157–194) (Schurr lab) R This study
PAO1 PA1504::Tn-Gm R This study
PAO1 PA0450::Tn-Gm R This study
PAO1 PA1370::Tn-Gm R This study
PAO1 PA0780::Tn-Gm R This study
PAO1 PA0780::Tn-Gm R This study
https://doi.org/10.1371/journal.pone.0216401.t001
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(PA5496-nrdJa, 5497-nrdJb), mucA22, PA0779 (ATP-dependent protease), katA (major cata-
lase KatA, [48]), rhlR (quorum sensing regulator, [49]), lon (Lon protease), nuoK (NADH
dehydrogenase subunit), norCB (NO reductase, [50], clinical strain FRD1 and a proven
A-NO2
- sensitive mucA22 mutant [51], respectively. As a control, we constructed a deletion
mutant of mucA (ΔmucA) and to our surprise, this strain was resistant to A-NO2-.
The mucA gene, mucoidy and alginate production in mucA22 vs. ΔmucA
strains
The immediate goal of our experimental plan moving forward was to assess the evolutionary
“rationale” underlying why the mucA22 mutation occurs so frequently in PA derived from
sputum from patients suffering from both CF and COPD airway disease [9, 36] and evaluate
whether a complete deletion of the mucA gene differed with respect to alginate production and
sensitivity to the potential translational CF and COPD therapeutic agent, A-NO2
-. As a
reminder, the mucA gene encodes a cytoplasmic membrane spanning anti-sigma factor that
binds the extra-cytoplasmic sigma factor AlgT(U) in the cytoplasm and is one of the most
common mechanisms for the conversion to mucoidy in both of the aforementioned diseases
[35]. The mucA gene is the second gene of an 11.524 kb alginate gene regulation operon
located between 831,301 and 842,825 bp on the PA chromosome (Fig 1, www.pseudomonas.
com). Other genes indicated by a minus sign (-) allow for mucoid conversion or alginate gene
regulation when mutated (e.g., negative regulators mucB,C,D, etc. [38, 39, 54].
Isogenic mucA1 and ΔmucA mutants in the PAO1 background were visibly mucoid on L-
agar plates (Fig 2A). The ΔmucA mutant (Δ157–194) was created in both the Hassett and
Schurr labs and confirmed by sequence analysis, S1A–S1C Fig). However, we must emphasize
that a complete in-frame deletion could not be constructed despite numerous attempts by
both laboratories and equipped with the appropriate mutagenesis constructs. Additionally, the
PA mucA22 and ΔmucA mutants were complemented in trans to the nonmucoid phenotype
using the wild-type mucA gene inserted into the arabinose-inducible pHERD20T plasmid (Fig
2A). Surprisingly, the ΔmucA mutant was found to generate significantly less alginate than
mucA22 (p = 0.012) but greater than the nonmucoid strain, PAO1 (Fig 2B). We also tested the
alginate stability phenotype in mucA22 vs. ΔmucA bacteria for it is well known that the process
of mucoid reversion (mucoid-to-nonmucoid phenotype) occurs when bacteria are grown
under aerobic static conditions [56]. Fig 2C indicates that mucoid stability is greater in
mucA22 versus ΔmucA bacteria after incubated for 48 hr.
Mucoidy and A-NO2
- planktonic sensitivity of mucA22, ΔmucA, and strain
FRD1 (mucA22) relative to PA
The sensitivity of each strain used in Fig 2A–2C to A-NO2
- in anaerobic planktonic cultures
was assessed, as well as the well-known CF mucA22 isolate known as FRD1 [9]. Surprisingly,
the ΔmucA mutant was found to be more resistant to A-NO2- relative to a sensitive mucA22
PA mutant. Strain FRD1 was even more sensitive to 15 mM A-NO2- than its mucA22 PA
PAO1-based mutant counterpart (Fig 3).
A-NO2
- sensitivity of mucA22 vs. ΔmucA in anaerobic biofilms
We have previously shown that anaerobic conditions favor more robust biofilm formation by
PA than aerobic conditions and that anaerobic conditions can exist in the thick CF airway sur-
face liquid [8], thereby limiting the overall efficacy of the powerful aminoglycoside, tobramy-
cin and other front-line antibiotics [57]. Thus, we next assessed the overall efficacy of A-NO2
-
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against mature, pre-formed anaerobic biofilms in strains PA, mucA22, ΔmucA and their com-
plemented strains. Fig 4A shows confocal laser scanning microscopy (CLSM) analysis results
of 1 day old biofilms of bacteria that were used for the planktonic A-NO2
- susceptibility assay.
These bacterial biofilms were continuously grown in LBN-pH 6.5 (control condition, NO3
-) or
LBN-pH 6.5 (treated condition, NO3
- 15 mM NO2
-) for 2 additional days. As shown in the
planktonic susceptibility assay, mucA22 strains were also more sensitive to A-NO2- than the
ΔmucA strain in bacterial biofilms that showed 37% and 25.5% cell death compared to control,
respectively (p = 0.029, Fig 4A and 4B). A-NO2- resistance complementation was achieved
using pHERDmucA. In some cases, the biofilm structure often was slightly altered, especially
in mucA-complemented bacteria which may be a function of multiple copies of cellular MucA.
Taken together, our results showed that mucA22 is more sensitive to A-NO2- than ΔmucA in
both planktonic and biofilm cultures.
Sensitivity of mucA22 but not ΔmucA PA to A-NO2- during chronic murine
lung infection
To test the role of MucA in A-NO2
- sensitivity in an animal model of infection, a chronic
murine lung infection model was employed as previously described with the exception that
strain PAO1 was not used for it is nonmucoid with a wild-type mucA allele [9]. Infected mice
Fig 1. Genetic map and function of the gene products of>12 kb genomic region containing the algT(U)mucABCD genes (scanned from www.
pseudomonas.com). The mucA gene immediately downstream of the algT(U) locus is circled. Minus signs (-) indicated genes involved in mucoid conversion
when mutated [35, 39, 54, 55].
https://doi.org/10.1371/journal.pone.0216401.g001
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were treated twice daily with 15 mM A-NO2
- for 5 days and the mice were then sacrificed. Fig
5 demonstrates that mucA22 were very sensitive to A-NO2- treatment when compared to
ΔmucA mutant bacteria. This is consistent with the planktonic and biofilm A-NO2- suscepti-
bility assay results.
Microarray analysis of wild-type, mucA22 and ΔmucA PA upon exposure to
A-NO2
-
Given that mucA22 mutant bacteria were more sensitive to A-NO2- than ΔmucA bacteria in
planktonic and biofilm culture as well as during murine airway infection, we next performed
transcriptional profiling experiments using wild-type PAO1, mucA22 and ΔmucA bacteria to
help elucidate the mechanism(s) underlying this apparent paradox. First, considerable efforts
were made to isolate quality RNA from A-NO2
- treated organisms. After many attempts and
various protocol adjustments, all three strains were grown for 24 hr under anaerobic condi-
tions in LBN, pH 6.5, followed by treatment of each organism with 15 mM A-NO2
- for 20 min.
Fig 2. Differences in the mucoid phenotype of the mucA22 and ΔmucA mutants. A. Colony morphology of wild-type, mucA22, and ΔmucA bacteria on L-agar plates
containing +/- of 0.1% arabinose which is the inducer of pHERD20T or pHERD20TmucA. B. Representative alginate levels (μg/ml) produced by PA wild-type (white
bar), ΔmucA (light gray bar) and mucA22 (black bar) bacteria, respectively (n = 3). C. Time course of aerobic mucoid reversion profile of mucA22 (solid line) vs. ΔmucA
(dashed line) bacteria (n = 3).
https://doi.org/10.1371/journal.pone.0216401.g002
Role of MucA in acidified nitrite sensitivity in P. aeruginosa
PLOS ONE | https://doi.org/10.1371/journal.pone.0216401 June 3, 2019 7 / 33
The number of genes in each functional class comparing (i) PAO1 vs. mucA22 (Fig 6A, S1
Table), (ii) PAO1 vs. ΔmucA (Fig 6B, S2 Table) and (iii) mucA22 vs. ΔmucA (Fig 6C, S3 Table)
are depicted, respectively. Interestingly, genes involved in NIR and NOR activity showed sig-
nificantly reduced expression in mucA22 bacteria anaerobic induction conditions, while the
expression of these genes was elevated in the ΔmucA mutant. This is consistent with the
A-NO2
- sensitivity phenotype of the mucA22 strain as this could lead to accumulation of toxic
NO2
-/NO in the bacteria as a result of inefficient use of the anaerobic respiratory pathway
involved in A-NO2
- metabolism: A-NO2
- > NO > N2O. Fig 6D is a Venn diagram synopsis of
gene overlap, the colors of which and the genes are also shown in Table 2.
Fig 3. Anaerobic A-NO2
- susceptibility assay in planktonic bacteria. Overnight planktonic cultures of PA wild-type strain PAO1 (filled circles), mucA22
(pHERDmucA) (closed squares), ΔmucA (open diamonds), ΔmucA (pHERDmucA) (open inverted triangle), mucA22 (open squares) as well as the A-NO2-
sensitive CF isolate FRD1 (closed circles) were diluted 1:100 into fresh LBN, pH 6.5 supplemented with 15 mM NaNO2, respectively. Cultures were incubated
anaerobically and sampled at the indicated times for CFU enumeration (n = 3).
https://doi.org/10.1371/journal.pone.0216401.g003
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Fig 4. (A) Assessment of A-NO2
- on PA (wild-type), mucA22 and ΔmucA mutant strains viability when grown
anaerobically as biofilms. Bacterial suspensions were diluted 100-fold in LBN, pH 6.5 and grown in Costar glass-
bottomed, chambers amenable to confocal laser scanning microscopic analysis. The planktonic cells were washed from
one-day old biofilms. The bacterial biofilms were separated into 2 conditions; control (LBN (NO3
-), pH 6.5) and
treated (LBN (NO3
-), pH 6.5 plus 15 mM A-NO2
- or NO3
-/NO2
-) conditions and continuously grown for 2 more days
under anaerobic condition. Both top and sagittal views of each live/dead stained biofilm are depicted after CLSM. Live
cells are green while red cells are dead (B) The ratio of percent cells dead was calculated by comparison between
control and treated conditions. The experiments were performed 3 times independently (n = 3).
https://doi.org/10.1371/journal.pone.0216401.g004
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Identification of S-nitrosylated proteins in A-NO2--treated bacteria
To further evaluate the response of PA to A-NO2-, a unique proteomic approach was used to
measure cysteine S-nitrosylation of cellular proteins mediated by NO generated from
A-NO2
-reduction, known as SNOSID (S-nitrosylation, SNO Site Identification, [58]). A-NO2-
treatment of bacteria allows for significant generation of what are termed S-nitrosylated pro-
teins (or SNO proteins, [59]). This technique was used to monitor PA proteins that had
increased or decreased levels of SNO-proteins in wild-type, mucA22 and ΔmucA strains. The
data collected are based upon SNO proteins in the 2-D gels shown in S2A–S2C Fig. Twelve
SNO proteins are presented in tabular form after mass spectrometric identification and their
relative levels expressed in each of the aforementioned strains listed in Table 3. Interestingly,
several of the proteins that showed differing levels of S-nitrosylation include those involved in
anaerobic metabolism (NirQ, NirS, NrdJB) or anaerobic survival (UspK, FdnG), alginate
Fig 5. Sensitivity of mucA22 vs. ΔmucA PA during a mouse chronic airway infection. Six-week old male Balb/C mice were infected intratracheally with
50 μl of ~5 x 106 of mucA22 or ΔmucA mutant strains suspended in 0.9% saline containing purified PA alginate (final concentration 1.1 mg/ml). After 24
hr, mouse lungs were instilled with 25 μl of 15 mM A-NO2- at pH 6.5 (in 0.1 M phosphate buffer) intranasally twice daily. On day 5 post-infection, the
mice were sacrificed, and the viable bacteria from serially diluted lung homogenates were enumerated (n = 8).
https://doi.org/10.1371/journal.pone.0216401.g005
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production (GDP-mannose dehydrogenase), the TCA cycle (succinate dehydrogenase, SdhB)
and virulence (Vfr).
Given that PA usp (universal stress protein) genes are necessary for long-term anaerobic
survival [60], we postulated that a double mucA22 uspK would be hyper-sensitive to anaerobic
A-NO2
- treatment. Fig 7 clearly confirms our hypothesis that this mutant is indeed more sus-
ceptible to A-NO2
- treatment than mucA22 mutant bacteria. We also identified that the FdnG
(formate dehydrogenase-O, major subunit, [61]) that is physically associated with NAR in vivo
[62], was identified to be S-nitrosylated. In comparison to the mucA22 uspK mutant, the
mucA22 fdnG double mutant was even more sensitive to A-NO2- (Fig 7).
Why is CF clinical strain FRD1 hypersensitive to A-NO2
- relative to PAO1
mucA22?
To determine whether mucoid CF strain FRD1 (i.e., a well-studied, chronically adapted CF
strain, [51]) had mutations other than mucA22 that might reveal clues as to why it is so sensi-
tive to A-NO2
- relative to PA mucA22, we assessed differences in the PA vs. FRD1 genome, the
latter of which was recently sequenced [63]. Specifically, we assessed potential mutations in
genes encoding anaerobic respiratory/regulatory genes in strain FRD1 that are not in strain
PA [63]. The PAO1 genome is comprised of 6,264,404 bp while that of the FRD1 genome has
6,712,339 bp total nucleotides, with a percent G+C content of ~66%, based upon data com-
piled from 133 contigs [63, 64]. A search and analysis of genes predicted to be involved in
A-NO2
-, resistance showed numerous single base pair substitutions. These included missense
mutations in genes such as several of the nar genes, as well as in nirS, and norCB among others
that would hypothetically affect A-NO2
-, sensitivity. However, during anaerobic conditions,
mutations within the norB or norC genes would likely influence sensitivity to A-NO2-.
Fig 6. Microarray assessment of gene classes that are activated (white bars) vs. repressed (black bars) in (A) wild-
type PAO1 vs. mucA22, (B) PAO1 vs. ΔmucA and (C) mucA22 vs. ΔmucA bacteria and (D) Venn diagram
indicating gene expression patterns that overlap with A-NO2
--treated anaerobic PAO1, mucA22 and ΔmucA
strains. The colors and the appropriate genes within each color subset are listed in Table 2, respectively.
https://doi.org/10.1371/journal.pone.0216401.g006
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Differences in the coding sequence of the PAO1 and FRD1 norB gene revealed a deletion of
Arg300 in the latter [63]. In strain PAO1, Arg300 is positioned in a highly basic loop that con-
sists of 4 consecutive arginine residues linking Helix IX and Helix X on the cytoplasmic side
(Fig 8). Arg300 forms a hydrogen bond with the carbonyl of Lys228 that caps the C-terminus
of Helix VI. Therefore, it is possible that loss of this interaction might result in conformational
changes that distort the binuclear centers of NorB, specifically His207, which is positioned on
Helix VI and is a ligand for FeB. When cloned into a PAO1 norCB mutant, the FRD1 norCB
genes could not rescue a normal anaerobic growth density (S4 Table).
Table 2. Overlapping differential gene expression corresponding to Fig 6D�.
PA0025_aroE_at PA0523_norC_at PA0525_at PA1059_at PA1083_flgH_at PA1837_at
A.(18) PA1838_cysI_at PA2687_pfeS_at PA3413_at PA3530_at PA3630_at PA3632_at
PA3880_at PA4155_at PA4156_at PA4158_fepG_at PA4161_fepG-at PA4896_at
PA0126_at PA0291_oprE_at PA0293_at PA0320_at PA0425_mexA_at PA0431_at
PA0548_tktA_at PA0549_at PA0792_prpD_at PA0793_at PA0794_at PA0795_prpC_at
PA0796_prpB_at PA0797_at PA1135_at PA1136_at PA1137_at PA1239_at
PA1805_ppiD_at PA2015_at PA2287_at PA2288_r_at PA2657_at PA2659_at
PA2840_at PA2934_at PA3008_at PA3118_leuB_at PA3119_at PA3120_leuD_at
B.(57) PA3195_gapA_at PA3748_at PA3787_at PA3932_at PA4030_at PA4059_at
PA4129_at PA4130_at PA4131_at PA4132_at PA4234_uvrA_at PA4636_at
PA4768_smpB_at PA4769_at PA4839_speA_at PA4853_fis_at PA4915_at PA4932_rplI_at
PA4933_at PA4935_rpsF_at PA5125_ntrC_at PA5147_mut_at PA5162_rmlD_at PA5136_rmlA_at
PA5304_dadA_at PA5383_at Ig_326671_3272284_at
PA0069_at PA0082_at PA0083_at PA0124_at PA0161_at PA0224_at
PA0286_at PA0353_ilvD_at PA0410_pilI_at PA0412_pilK_at PA0413_at PA0526_at
PA0558_at PA_0669_at PA0670_at PA0731_at PA0765_mucC_at PA0906_at
PA0910_at PA0911_at PA0933_ygcA_at PA0938_at PA1048_at PA1431_rsaL_at
PA1541_at PA1588_sucC_at PA1589_sucD_at PA1746_at PA2277_arsR_at PA2290_ged_at
PA238-1_at PA2445_gcvP2_at PA2639_nuoD_at PA2640_nuoE_at PA2641_nuoF_at PA2642_nuoG_at
PA2643_nuoH_at PA2646_nuoK_at PA2648_nuoM_at PA2664_fhp_at PA2667_at PA2705_at
C.(83) PA2706_at PA2718_at PA2788_at PA2796_tal_at PA2846_at PA2869_at
PA2946_at PA2948_cobM_at PA3011_atopA_t PA3012_at PA3013_foaB_at PA3066_at
PA3067_at PA3181_at PA3392_nosZ_at PA3471_at PA3567_at PA3575_at
PA3620_mutS_at PA3859_at PA3972_at PA3973_at PA4006_at PA4007_proA_at
PA4045_at PA4046_at PA4061_at PA4068_at PA4180_at PA4440_at
PA4493_at PA4499_at PA4625_at PA4803_at PA4812_fdnG_at PA4919_pncB1_at
PA5479_gltP_at PA5496_at PA5557_atpH_at PA5564_gidB_at PA5565_gidA_at
PA0510_at PA0515_at PA0561_nirF_at PA0518_nurM_at PA0520_nirQ_at PA0764_mucB_at
D.(12) PA0766_mucA_at PA1423_lasI_at PA2830_htpX_at PA3971_at PA4810_fdnI_at PA5429_aspA_at
PA0201_at PA0280_cysA_at PA0281_cysW_at PA0283_sbp_at PA0284_at PA0396_pilU_at
E.(12) PA0524_norB_at PA2599_at PA3446_at PA3450_at PA3931_at PA4443_cysD_at
PA0045_at PA0179_at PA0432_sahH_at PA0546_metK_at PA0547_at PA0671_at
PA1132_at PA1423_at PA1587_lpdG_at PA1865_at PA2644_nuoI_at PA2658_at
F.(25) PA2662_at PA2663_at PA3472_at PA3551_algA_at PA3747_at PA4033_at
PA4630_at PA4971_at PA5203_gshA_at PA5250_at PA5251_at PA5252_at
PA5483_algB_at
G.(3) PA0517_nirC_at PA0519_nirS_at PA0807_at
�Overlapping gene groups (probe set ID) are colored as the Venn diagram showing in Fig 6D.
https://doi.org/10.1371/journal.pone.0216401.t002
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Discussion
Anaerobic A-NO2
- sensitivity: intuitive and nonintuitive gene products
involved in its defense
The mucA22 allele in PA is the most common mutation (deletion of a C residue at position 430)
found during the course of chronic CF and COPD, resulting in a truncated MucA protein of
~15.8 kDa and resulting mucoid conversion (alginate-overproduction). A little over 13 years ago,
we discovered that mucoid, mucA22 mutant PA were uniquely susceptible to A-NO2- at the
slightly acidic pH that is consistent with that of the CF (pH 6.4–6.5 [9, 66] and COPD airway sur-
face liquid [67], effectively revealing a previously unrecognized “Achilles heel” of these highly
refractory organisms. This weakness was a significant translational development given that
mucA22 organisms are formidably antibiotic- and phagocyte-resistant. Prior to that work, two
seminal papers describing the anaerobic biofilm mode of growth in CF were published in 2002 [8,
13]. Since then, dedicated research efforts have ensued to unravel the biology of the ever-evolving
organisms cultured from anaerobic CF and COPD airway biofilms. In addition, the slightly acidic
nature of CF and COPD airways allows for A-NO2
- to be reduced to NO, that we have shown is
known to kill not only mucA22 mutant PA, but also S. aureus (MRSA) and B. cepacia [29].
Thus, given these clinically relevant and translational developments (U.S. Patent #
8,557,300 B2 by corresponding author), the primary goal of this study was to identify addi-
tional genes involved in A-NO2
- sensitivity or resistance. Using both transposon and strategic
insertion or deletion mutagenesis approaches, a series of mutants displaying the aforemen-
tioned traits were discovered. First, we showed that the major catalase, KatA, is required for
anaerobic A-NO2
- resistance because of its surprisingly inherent ability to buffer the NO
derived from A-NO2
- reduction [48]. Second, a mutant defective in the rhl quorum sensing
circuit regulator (rhlR), that we have also found previously to commit an anaerobic suicide by
overproduction of endogenous respiratory NO in biofilms [8], was also found to be sensitive
to exogenous anaerobic A-NO2
-. Other genes that were necessary for optimal A-NO2
-
Table 3. Identification of SNO proteins from the different bacteria used in this study. For example, the fold change in spot 2A (FdnG) in the mucA22 mutant is
2.2-fold more S-nitrosylated than wild-type bacteria.
Spot ID Gene/protein name Fold change�
mucA22 vs PAO1 ΔmucA vs PAO1 ΔmucA vs mucA22
Up Down Up Down Up Down
2A fdnG 2.2 - 2.4 - - -
2B fdnG 13 - 6.3 - - 2.1
5 ygbM - - - - - 1.5
6A nrdJB - 1.4 - - 1.3 -
6B nrdJB - 1.9 - 1.6 1.2 -
7 priC or opdA 1.7 - 1.7 - - -
8 algD - - 1.5 - 1.5 -
10 uspK - 1.7 - 2.4 - 1.4
11 Vfr - 6.7 - 7.1 -
13 nirS - - - 2.3 - 2.1
15 oprH - 3.2 - - 2.9 -
17 prpB or bcpA - 1.2 1.4 - 1.7 -
18 nirQ 1.7 - - - - 1.7
19 galU - 1.4 - 1.3 - -
� = Relative SNO protein expression levels.
https://doi.org/10.1371/journal.pone.0216401.t003
Role of MucA in acidified nitrite sensitivity in P. aeruginosa
PLOS ONE | https://doi.org/10.1371/journal.pone.0216401 June 3, 2019 13 / 33
resistance included another quorum sensing regulator gene, pmpR (regulator of the Pseudomo-
nas quinolone signal (PQS), [68]), lon (encoding the Lon protease), PA4455 (a putative ABC
transporter, [47]), and nrdJa,b (encoding anaerobic ribonucleotide reductase). The Lon prote-
ase has previously been shown to be required for optimal activity of Fhp (flavohemoglobin), an
aerobically expressed flavohemoglobin with aerobic but not anaerobic NO detoxifying proper-
ties [69, 70]. Thus, it makes perfect sense that the PA0779 (asrA, a Lon peptidase) mutant is
also sensitive to A-NO2
-. However, the most intriguing results of this study and given the pre-
dominance of mucA mutations from predominantly CF and to a lesser extent COPD were
from A-NO2
- sensitivity and insensitivity results comparing mucA22 vs. ΔmucA bacteria, the
latter of which was found to be paradoxically resistant to it in planktonic, biofilm and during a
chronic murine lung infection. Thus, the remainder of this study focused on understanding
the mechanism underlying this puzzling development.
Microarray and SNO protein analyses and interpretations upon exposure
of bacteria to A-NO2
-
To better understand why wild-type and ΔmucA strains were less sensitive to A-NO2- than
mucA22 bacteria, we strategically performed transcriptional profiling of wild-type, mucA22
Fig 7. A-NO2
- sensitivity of anaerobic planktonic PAO1 (diamonds) mucA22 mutant (squares) with secondary
mutations in uspK (strikethrough squares) and fdnG (triangles). We must note that there were no observable
differences in the growth patterns of mucA22 and the double mutants.
https://doi.org/10.1371/journal.pone.0216401.g007
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and ΔmucA strains exposed to anaerobic A-NO2-. We found that wild-type bacteria and the
ΔmucA mutant had far higher transcriptional levels of protective nir (encoding NIR), nor
(encoding NOR) and fhp (encoding flavohemoglobin) genes when compared to the very low
transcription of such genes in the mucA22 mutant. This is consistent with the very low tran-
scription of nir and nor genes in anaerobic clinical isolate FRD1 (a mucA22 mutant) exposed
to A-NO2
- as we have described previously [9]. In addition, many nuo genes (encoding NADH
dehydrogenase) were also upregulated in the ΔmucA mutant. It is not surprising that the
nuoABDFHIJKMN genes are also required for anaerobic growth with both NO3- and NO2- as
terminal electron acceptors [71, 72]. Thus, the wild-type and ΔmucA mutant have a greater
ability to detoxify both NO2
- and NO. Another interesting observation from the transcrip-
tional profiling was that wild-type PAO1 and the muc22 mutant have normal expression of
mucD, the last gene of the algT/U operon, but the ΔmucA mutant has 5-fold less expression.
MucD is a periplasmic protease that serves as a weak negative regulator of AlgW protease,
which senses periplasmic stress, leading to cleavage/activation of MucA [73]. This alteration in
the AlgT(U) (σ22) pathway might affect expression of nir, nor, and fhp genes, which is currently
under investigation. However, the ΔmucA strain has 27 extra amino acids than the mucA22
mutant, begging the question as to whether these amino acids are involved in the anaerobic
respiratory pathway vis a vis protection against NO.
To complement our transcriptomic data, our S-nitrosylation analysis also revealed mecha-
nistic clues from the protein level. As a reminder, S-nitrosylation is a mechanism of signal
Fig 8. Position of Arg300 in the structure of PA NorB. Ribbon representation of NorB (PDB:3o0r) [65] in two orientations. Arg300 is show in stick format.
Helix IV is colored red and the heme centers are show in spacefill. Arg300 hydrogen bonds to the mainchain carbonyl of Lys288 is shown in the right panel.
https://doi.org/10.1371/journal.pone.0216401.g008
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transduction in eukaryotes based upon a covalent bond between NO and cysteine residues,
thereby serving as a post-translational modification [74]. In bacteria, however, S-nitrosylation
can actually be used to trigger anaerobic gene transcription mediated, as seen by SNO-medi-
ated activation of OxyR in E. coli [75]. The most S-nitrosylated proteins (an event that can
compromise protein function) have significant links to the overall anaerobic respiratory cas-
cade of PA. These include NrdG (a regulator of nrdJa,b genes), NirS (NIR), NirQ [76], NrdJa
(anaerobic ribonucleotide reductase (RNR)) and NuoL (NADH dehydrogenase chain L).
Other than nirS, it should be noted that all of the aforementioned genes are essential for anaer-
obic growth [77], especially the Class II RNRs [78]. Thus, we believe that S-nitrosylation is a
consequence of exposure to A-NO2
-. However, we also believe that the NO generated by
A-NO2
- reduction overwhelms the machinery involved in the transcription of the protective
norCB genes (encoding NO reductase). In 2007, we showed that high (~16 μM) endogenous
levels of NO inactivate the ANR/DNR regulatory cascade in a norCB mutant, leading to abys-
mally poor growth under anaerobic conditions [50].
What could be the mechanism of A-NO2
- toxicity in anaerobic mucA22
mutant PA relative to that of a ΔmucA mutant?
There are at least five possible mechanisms of cell injury and death from A-NO2
- in mucA22
mutant bacteria, (a) inhibition of heme-enzyme(s), (b) destruction of iron-sulfur (Fe-S) cen-
ters (e.g., the master anaerobic transcriptional regulator ANR, an NO-sensitive 4Fe-4S cluster
protein, [50]), (c) disruption of cellular iron homeostasis (with a,b,c being primarily via the
formation of dinitrosyliron complexes [48]), (d) oxidative injury (upon introduction to an aer-
obic environment), and (e) protein adduction (nitration, nitrosation). NO reacts with only
two groups of species under biological conditions, other radicals (such as O2 and O2
•-) and
transition metals. At first glance (however vide infra), oxygen radical-based death can be ruled
out because of the strict anaerobiosis enforced in these studies given the fact that both CF and
COPD airways have anaerobic airway pockets, leaving likely transition metal interactions as
the major mechanism(s) of NO toxicity. Most cellular metal ions are “shielded” from NO and
thus are not likely targets. The “classic” metal targets are iron and heme-containing (those
with an open ligation position), Fe-S centers, and the “chelatable iron pool” (CIP) [79–84].
Final questions that urgently need answers
What might be the biological functions of MucA vs. MucA22: are there potentially other
binding partners during anaerobic growth other than the extracytoplasmic sigma factor,
AlgT(U) and the periplasmic negative regulator MucB? The most intriguing finding of this
work was the discovery that mucA22 and ΔmucA bacteria behave very differently vis a vis
A-NO2
- susceptibility patterns. Our results suggest that the 15.8 kDa truncated MucA22 pro-
tein has an unknown function that is possibly to dysregulate the anaerobic respiratory regula-
tory and enzymatic genetic circuitry. In support of this notion, and based upon this pioneering
work, we have previously shown that NIR and NOR genes are dramatically down-regulated in
mucA22 bacteria relative to wild-type organisms [9]. As a final attempt to build the hypothe-
sis-driven platform for a future study, we elected to use bioinformatic techniques to elucidate
further clues as to why mucoid mucA mutants are more sensitive to A-NO2- than wild-type,
nonmucoid bacteria. To accomplish this goal, our microarray data were analyzed to identify
differentially expressed genes (DEGs) between three conditions (anaerobic PA, mucA22 and
ΔmucA exposed to 15 mM A-NO2-, pH 6.5 in pairs. The significant DEGs were selected by the
criteria that fold change values are larger than two and the p-value is lower than 0.05. We also
compared the significant DEGs under each comparison design based upon the microarray
Role of MucA in acidified nitrite sensitivity in P. aeruginosa
PLOS ONE | https://doi.org/10.1371/journal.pone.0216401 June 3, 2019 16 / 33
data and looked for overlapping genes to investigate if the transcriptional profile changes were
contributing to the hypersensitivity of A-NO2
- in mucA22 mutant bacteria when compared to
wild-type and ΔmucA). The functional annotation clustering of the gene set was conducted by
DAVID to see if any functional pathway was related with alternative gene expression. If the
overlapping genes were also found in the mucA22 vs. ΔmucA analyses, it indicates that the
genes expressed differently should have a tight interaction with MucA. To elucidate the mech-
anism underlying A-NO2
- sensitivity as well as identifying potential interacting partners of
MucA, we searched an on-line PA PAO1 protein-protein interaction (PPI) database (http://
research.cchmc.org/PPIdatabase) using the query word MucA. This database contains predic-
tion results by a random forest classifier that was trained on nine genomic features (co-essenti-
ality, co-expression, co-functionality, co-localization, domain-domain interaction, co-pathway
involvement, transmembrane helices, co-operon and co-gene cluster involvement, [85]). This
assessment resulted is a large-scale PPI network in PA with significant coverage and high accu-
racy, i.e., 57,746 potential protein interactions covering 4,256 PA PAO1 proteins [86]. Among
the DEGs, we selected the potential PPI partners of MucA from the interactome database. By
querying MucA in the database, we found 17 proteins with which it is predicted to interact (S5
Table, Fig 9). We also searched the STRING database (https://string-db.org) for MucA interac-
tors. The top 20 interactors of high confidence interaction with MucA were used for the fol-
lowing analysis. Five proteins are in common between the interactors predicted by two
sources. In total, 32 MucA interactors were predicted (S6 and S7 Tables). We then investigated
if these interactors changed expression in the ΔmucA or mucA22 mutants compared to wild
type PAO1. Five interactors were found significantly altered expression in PA vs ΔmucA,
including three muc genes (mucBCD), algA and nirC, respectively. In contrast, when PAO1
gene expression was compared to the mucA22 mutant, only levels of algA and nirC transcrip-
tion were found significantly changed. Interestingly, only the nirC gene was found differen-
tially expressed in all three strains comparisons. In fact, nirC expression was highest in the
mucA22 mutant and down-regulated in the ΔmucA mutant when compared to PAO1 expres-
sion. This pattern indicates that the expression of the nirC gene is more likely to be influenced
by any changes in the mucA gene, and the expression level may be correlated to the A-NO2-
sensitivity phenotype. We identified possible anaerobic binding partners for MucA, NirC and
NirM. Both NirC and NirM are periplasmic c-type cytochromes that are known to donate elec-
trons to NIR, thereby promoting efficient anaerobic respiration [87]. These data indicate that
there is a distinct possibility that anaerobic MucA22 has a function other than binding to AlgT
(U) and MucB. Relatedly, an anaerobic protein “interactome” has been shown linking the pri-
mary motility protein, flagellin (FliC) with NirS and DnaK [88]. Very complex yet interesting
biology was revealed in the aforementioned work. First, a nirS mutant could not form a flagel-
lum and as such was impaired in swimming motility. Conversely, if the flagellum and anaero-
bic respiration are coordinately regulated in an as yet unappreciated pathway, then a fliC
mutant should be impaired in anaerobic respiration—which was not the case. The other inter-
esting feature between flagellar expression and mucoidy is that fliC is repressed by the AlgT
(U)-dependent regulator AmzR that directly represses the fleQ gene, the product of which is
required for fliC transcription [89]. We have previously shown that mucoid mucA22 mutant
bacteria grow poorly anaerobically because they harbor dramatically lower respiratory NAR
and NIR activity [9].
Closing remarks
Finally, this multi-disciplinary study revealed a fascinating paradox in that ΔmucA mutant bac-
teria possess an anaerobic A-NO2
—resistant phenotype relative to that of mucA22 mutant
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bacteria. This is consistent with the myriad of strains (>300) that have been sequenced in sev-
eral studies indicating that that no mucoid strains would be classified as true deletion mutants
and we could not engineer a complete deletion despite numerous attempts [9, 35]. Given the
numerous discoveries and scientific disciplines used in this study, we elected to provide a syn-
opsis flow chart that is detailed in Fig 10 as a refresher and eliminate any potential confusion.
This figure is divided into (i) initial screen, (ii) unexpected discovery, (iii) mechanistic evalua-
tion and (iv) future studies. Lastly, future studies are designed to identify putative anaerobic
MucA and potentially MucA22 binding partners in the context of better understanding the
important translational implications of A-NO2
- treatment for killing of highly refractory air-
way infectious bacteria in CF and COPD.
Fig 9. Integrated protein interaction networks. A. Inset. Simplified version of the integrated protein interaction networks. B. Fifteen proteins encoded by
the genes involved in A-NO2
- sensitivity (green nodes; overlapping DEGs of PA vs mucA22 and ΔmucA vs mucA22) and 32 predicted MucA interactors (red
nodes) were used to build an integrated protein interaction network. The genes labeled in red were also found differentially expressed between PA vs ΔmucA.
https://doi.org/10.1371/journal.pone.0216401.g009
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Materials and methods
Bacterial strains and growth conditions
All bacteria, including newly constructed mutants and plasmids used in this study are listed in
Table 4. Organisms were routinely grown in either Luria-Bertani broth (L-broth) or L-broth
plus 100 mM KNO3 (LBN) or LBN pH 6.5 which is LBN containing 50 mM potassium phos-
phate. Aerobic cultures were grown at 37˚C with shaking at 250 rpm at a 1/10 volume to total
Erlenmeyer flask ratio. Media were solidified with 1.5% Bacto-agar. Bacteria were grown
Fig 10. Flow chart of the scientific progress in this study split into (i) initial screen, (ii) unexpected discovery, (iii) mechanistic evaluation and (iv) future
studies sections. Green arrows indicate upregulated genes while the red arrows indicate down-regulated genes. NAR, nitrate reductase; NIR, nitrite reductase;
NOR, NO reductase; NOS, nitrous oxide reductase. The future studies diagram is an inner (IM) and outer (OM) of nonmucoid and mucoid PA with AlgT(U),
MucA, MucA22 and MucB in their known cellular locations [90].
https://doi.org/10.1371/journal.pone.0216401.g010
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under anaerobic conditions at 37˚C in a dual-port Coy Laboratories anaerobic chamber. Fro-
zen bacterial stocks were stored at -80˚C in a 1:1 mixture of 30% glycerol and stationary-phase
bacterial suspension.
Manipulation of recombinant DNA and genetic techniques
All plasmid and chromosomal nucleic acid manipulations were performed by standard tech-
niques [99]. Plasmid DNA was transformed into E. coli strain DH5α (Protein Express, Cincin-
nati, OH). To detect the presence of insert DNA, X-Gal (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside; 40 μg/ml) was added to agar media. Restriction endonucleases, the Klenow
fragment of DNA polymerase I, T4 DNA polymerase, and T4 DNA ligase were used as speci-
fied by the vendor (Invitrogen/ Gibco-BRL Corp., Gaithersburg, MD). Plasmid DNA was
Table 4. Bacterial strains, plasmids and oligonucleotides used in this study.
Strain, plasmid or
oligonucleotide
Description (relevant genotype or phenotype) or sequence (50 to 30) Company source or
reference
E. coli
DH5α F- F80dlacZΔM15 endA1 recA1 hsdR17(rK- mK-) supE44 thi-1 gyrA96 Δ(lacZYA-argF)U169 Invitrogen
S17-1 λ pir Pro− Res− Mod+ recA; integrated RP4-Tet : : Mu-Kan : : Tn7, Mob+ [91]
P. aeruginosa
PAO1 Wild-type laboratory strain [92]
FRD1 Mucoid CF clinical isolate with mucA22 allele [93]
mucA22 PAO1 mucA22 mutant, mucoid [94]
ΔmucA PAO1ΔmucA mutant (Δ157–194) (Hassett and Schurr labs) This study
mucA22 uspK mucA22, uspK::TnGm This study
mucA22 fdnG mucA22, fdnG::TnGm This study
moaA2 moaA2::TnGm This study
PA4455 PA4455::Gm [47]
PA0964 PA0964::TnGm This study
PA0450 PA0450::TnGm This study
rhlR rhlR::Gm [52]
norCB norCB::Gm [50]
lon lon::TnGm This study
nuoK nuoK::TnGm This study
Plasmids
pBT20 Mini-Tn delivery vector, ApR, GmR [95]
pUCGM Source for Gmr cassette, ApR, GmR [96]
pEX100T-KS Pseudomonas gene replacement suicide vector with modified multiple cloning site, sacB, oriT, CbR [97]
pEXO100T GmR cassette from pUCGM was inserted into unique ScaI site of pEX100T-KS, sacB, oriT, GmR This study
pEXO100TΔmucA 1kb upstream and downstream fragments flanking mucA gene were cloned into pEXO100T, sacB,
oriT, GmR
This study
pHERD20T Escherichia-Pseudomonas shuttle vector, ApR [98]
pHERDmucA mucA cloned into pHERD20T This study
Nucleotides
AD2 50-cangctwsgtntscaa
Gm447 50-gtgcaagcagattacggtgacgat
Gm464 50-tgacgatcccgcagtggctctc
ApR, ampicillin resistant; CbR, carbenicillin resistant; GmR, gentamicin resistant
https://doi.org/10.1371/journal.pone.0216401.t004
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isolated by using plasmid miniprep isolation kits (Qiagen), and restriction fragments were
recovered from agarose gels by using SeaPlaque low-melting-point agarose (FMC BioProducts,
Rockland, ME). PCRs were performed by using Pfu DNA polymerase (BRL) and appropriate
primers in an MJ Research thermal cycler, with 30 cycles of denaturation (2 min, 94˚C),
annealing (1 min, 54˚C), and extension (1 min 30 s, 72˚C). Amplified DNA fragments were
gel purified, cloned into pCR2.1 (Invitrogen), and sequenced.
Methods used to construct PA mutant strains
Screening of more sensitive or resistance A-NO2
- strains using Transposon (Tn) muta-
genesis. PA strain PAO1 was subjected to transposon (Tn) mutagenesis using the mariner
transposon vector, pBT20 [95]. The transposon within pBT20 was conjugally transferred by
biparental mating using E. coli S17-1 λ pir into strain PAO1 as previously described [95]. An
overnight broth culture of the donor strain (2 ml of stationary phase culture) and 0.5 ml of the
recipient strain were clarified by centrifugation and resuspended in 0.5 ml of L-broth. This
concentrated suspension was then spotted on the center of a L-broth plate, allowed to dry, and
incubated for ~18 hr at 37˚C. Mating mixtures were scraped and resuspended in 1 ml of L-
broth. Suspensions (300 μl) were spread evenly onto Pseudomonas isolation agar (PIA) con-
taining gentamicin (Gm) at 150 μg/ml and incubated at 37˚C for 48 hr. The resulting growth
was scraped from the plate and resuspended in 2 ml of 0.9% saline and serial dilutions plated
onto freshly prepared LBN plates, pH 6.5 containing 15 mM acidified NaNO2 (A-NO2
-).
Transposon insertion sites were determined through sequencing the flanking region of the
transposon by a semi-random PCR method, as described previously [100] using random
primer AD2 and transposon-specific primer Gm447, followed by the nested primers Gm464
and AD2 (Table 1). Individual colonies were patched to L-broth plates and L-broth A-NO2
-,
pH 6.5 plates containing 15 mM KNO3 with either 15 mM or 25 mM NaNO2 for selection of
sensitive and resistance strains, respectively. Cells were grown aerobically for 24 hr and anaer-
obically for up to 48 hr. Those organisms that grew on the 25 mM NaNO2 plates were consid-
ered A-NO2
- resistant while cells that did not grow on 15 mM NaNO2 plates were considered
A-NO2
—sensitive. Confirmation of the A-NO2
- sensitive or resistance phenotype was followed
by an A-NO2
- killing assay by enumeration of remaining CFU after treatment. Briefly, the
overnight culture was diluted 1000-fold into L-broth pH 6.5, 50 mM phosphate buffer contain-
ing either 15 mM KNO3 or 15 mM NaNO2, respectively. Cell viability was monitored daily for
3 days. All experiments were performed at least 3 times and reproducible mutants were then
assessed for the identity of the specific gene interrupted by the transposon. The genomic DNA
was isolated and the identification of the transposon integration site was initiated by semi-ran-
dom PCR. The resulting PCR amplification products were subjected to DNA sequence analysis
at the Cincinnati Children’s Hospital DNA core (Cincinnati, OH).
Allelic exchange and sucrose counter-selection for construct of mutants. The strategy
for insertional inactivation of PA genes (Table 1) was facilitated by gene disruption with an
850-bp GmR cassette from pUCGM (52), and the gene replacement vector pEX100T-KS (29),
the latter of which allowed for selection of double-crossover events within putative recombi-
nants cultured on agar containing 5–6% sucrose. To facilitate construction of an unmarked
nonpolar mucA deletion mutant, the GmR cassette from pUCGM was inserted into unique
ScaI site of pEX100T-KS, creating plasmid pEXO100T. Approximately 1 kb of upstream and
downstream fragments of the mucA gene was PCR amplified, and cloned into the HindIII and
SpeI sites of pEXO100T. The resultant plasmid, pEXO100TΔmucA, was used to construct a
mucA deletion mutant (herein termed ΔmucA) that contained a downstream constitutive pro-
moter to ensure transcription of the mucB gene. All mutants were confirmed by DNA
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sequencing of amplified PCR products. Two independent mucA deletion mutants from the D.
J.H. and M.J.S. laboratories were also confirmed by Illumina sequencing (S1 Fig) and the con-
tigs were assembled using the PATRIC alignment program. Other mutants that we suspected
to be sensitive to A-NO2
- from previous studies and our own literature-based hypotheses are
also listed in Table 4. Some other mutants listed in Table 4 were also constructed using this
method.
Planktonic culture measurements of A-NO2
- sensitivity. Overnight cultures of PA and
various Tn and/or allelic exchange mutants were 1:100 diluted into either LB broth (pH 6.5) or
LBN broth (pH 6.5, the pH of CF airway surface liquid, [9]) supplemented with varying con-
centrations of NaNO2 (0, 5, 10, 15, 20, 25 and 30 mM, hence the term A-NO2
-) and grown
anaerobically for 48 hr. Five μl of cells from each culture was serially diluted and spotted onto
LB agar plates and incubated aerobically for 24 hr at 37˚C. The plates were then scanned for
enumeration of CFU. (ii) Some strains were also cultured anaerobically for 72 hr in LBN broth
(pH 6.5) supplemented with either 0, 20, or 25 mM NaNO2 for strain PAO1, ΔmucA and
mucA22 mutants, as well as mucA22 uspK and mucA22 fdnG, respectively. Cultures were pro-
cessed daily, and serial cell dilutions were spotted onto L-agar plates. Surviving bacteria were
enumerated after a 24 hr incubation at 37˚C.
Anaerobic biofilm A-NO2
- sensitivity measurements. Bacteria were grown aerobically
in LB broth to stationary phase followed by a 1:100 dilution into 3 ml of LBN in confocal
friendly glass bottomed chambers (Costar). Static bacterial biofilms were allowed to develop
under anaerobic condition as previously described [8]. After 24 hr, biofilms were washed with
sterile PBS to remove planktonic cells, and fresh LBN broth (pH 6.5) containing 15 mM KNO3
(control), or 15 mM KNO3 plus 15 mM NaNO2 was added to the bacteria biofilm cultures.
The biofilms were then incubated under anaerobic conditions for an additional of 48 hr,
washed 2 times with PBS, and stained with Live/Dead BacLight bacterial viability kit (Invitro-
gen, Eugene, OR). Biofilm images were viewed by confocal laser scanning microscopy using a
Zeiss LSM 710 confocal microscope and visualized the live cells in green and the dead cells in
red. The excitation and emission wavelengths for green fluorescence (live cells) were 488 nm
and 500 nm, while those for red fluorescence (dead cells) were 490 nm and 635 nm, respec-
tively. All biofilm experiments were repeated at least 3 times independently. The live/dead
ratio of the biofilms were calculated using imageJ 1.46r software following the guidelines by
the University of Chicago Integrated Light Microscopy Core. The results are presented as the
differences in the dead/live ratio comparing A-NO2
-treated versus control conditions.
Transcriptional profiling using Affymetrix GeneChips of PA, mucA22 and ΔmucA
strains exposed to A-NO2
-. PA, mucA22 and ΔmucA bacteria were grown anaerobically for
24 hr in LBN, pH 6.5, followed by the addition of 15 mM NaNO2 (A-NO2
-) for an additional
20 min. Organisms were then pelleted by centrifugation at 13,000 x g for 5 min and the pellets
resuspended in RNAlater (Ambion) to prevent bacterial RNA degradation and to stabilize the
bacterial mRNA. To assess quantitative gene expression analysis of PA, Affymetrix GeneChips
were used. RNA from PA was isolated by using Qiagen RNeasy columns according to the man-
ufacturer’s protocol for isolation of total RNA. RNA from three independent samples was iso-
lated for hybridization on three independent Pseudomonas GeneChips. Once the RNA was
eluted from the Qiagen RNeasy column, then RNA was treated with 2 U of DNase I (Ambion)
for 15 min at 37˚C. The reaction was stopped by the addition of 25 μl of DNase stop solution
(50 mM EDTA, 1.5 M sodium acetate and 1% SDS). The DNase I was removed by phenol/
chloroform extraction followed by ethanol precipitation. The approximate amount of RNA
isolated was quantified using spectrophotometer. To determine the quality of the RNA, sam-
ples were analyzed on an Agilent bioanalyzer 2100. The quality of RNA was determined by
examining the 16S and 23S rRNA bands on the electrophoretogram that should be at a 1:1
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ratio. Ten μg of total RNA was used for cDNA synthesis, fragmentation and labeling according
to the Affymetrix GeneChip PA Genome Array Expression Analysis pProtocol. Briefly, ran-
dom hexamers (Invitrogen) were added (final conc. 25 ng/μl) to the 10 μg of total RNA along
with in vitro transcribed B. subtilis control spikes (as described in the Affymetrix GeneChip
PA Genome Array Expression Analysis Protocol). cDNA was synthesized using Superscript II
(Invitrogen) according to the manufacturer’s instructions under the following conditions:
25˚C for 10 min, 37˚C for 60 min, 42˚C for 60 min, 70˚C for 10 min. RNA was removed by
alkaline treatment and subsequent neutralization. The cDNA was purified by a QIAquick PCR
purification kit (Qiagen) and eluted in 40 μl of elution buffer (10 mM Tris-HCl, pH 8.5). The
cDNA was then fragmented by DNase I (0.6 U per μg cDNA, Amersham) at 37˚C for 10 min
and end-labeled with Biotin-ddUTP using the Enzo BioArray Terminal Labeling kit (Affyme-
trix) at 37˚C for 60 min. Proper cDNA fragmentation and biotin labeling were determined by
gel mobility shift assay using NeutrAvadin (Pierce) and on a 5% polyacrylamide gel stained
with SYBR Green I (Roche). The labeled cDNA was hybridized to the Affymetrix Pseudomonas
GeneChip according to the manufacturer’s protocol. Microarray data was generated using
Affymetrix (www.affymetrix.com) protocols as we have done previously [72, 101]. We used
Affymetrix data previously obtained from PA grown from three independent samples as the
control for gene expression comparisons.
Microarray data analysis. Microarray data were generated and analyzed using Affymetrix
protocols as previously described [102–104]. Probe set summarization (.CHP) files were gener-
ated using the Affymetrix MicroArray Suite 5.0 (MAS 5.0) algorithm. The absolute expression
transcript levels were normalized for each chip by globally scaling all probe sets to a target sig-
nal intensity of 500. Three statistical algorithms (detection, change call, and signal log ratio)
were used to identify differential gene expression in experimental and control samples. The
decision of a present, absent, or marginal identification for each gene was determined by using
MicroArray Suite software (version 5.0; Affymetrix). Those transcripts that received an
“absent” designation were removed from further analysis. A t test was used to isolate those
genes whose transcriptional profile was statistically significant (P< 0.05) between the control
and experimental conditions. Pair-wise comparisons between the individual experimental and
control chips were done by batch analyses using MicroArray Suite to generate a change call
and signal log ratio for each transcript. A positive change was defined as a call whereby more
than 50% of the transcripts increased or marginally increased for up-regulated genes or
decreased or marginally decreased for down-regulated genes. Lastly, the median value of the
signal log ratios for each comparison was calculated and only transcripts that had a value
greater than or equal to 1 for up-regulated and less than or equal to 1 for down-regulated
genes were placed on the final list of transcripts whose profile had changed. The signal-log
ratio was converted and expressed as the change (n-fold). The microarray data are available on
the GEO (Gene Expression Omnibus) website at http://www.ncbi.nlm.nih.gov/projects/geo
(GEO accession no. GSE128220).
Bioinformatic analysis of differential gene expression
The microarray data were analyzed to identify differentially expressed genes (DEGs) between
three conditions (anaerobic PA, mucA22 and ΔmucA exposed to 15 mM A-NO2-, pH 6.5 for
20 min) in pairs. The significant DEGs were selected by the criteria that fold change values are
larger than two and the p-value is lower than 0.05. To elucidate the mechanism underlying
A-NO2
- sensitivity as well as identifying potential interacting partners of MucA, we searched
an online PA PAO1 protein-protein interaction (PPI) database (http://research.cchmc.org/
PPIdatabase) using the query word MucA. This database contains prediction results by a
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random forest classifier that was trained on eight genomic features (co-essentiality, co-expres-
sion, co-functionality, co-localization, domain-domain interaction, co-pathway involvement,
transmembrane helices, co-operon and co-gene cluster involvement). The result is a large-
scale PPI network in PA with significant coverage and high accuracy, i.e., 57,746 potential pro-
tein interactions covering 4,256 PA PAO1 proteins [86]. Among the DEGs, we selected the
potential PPI partners of MucA from the interactome database. We also compared the signifi-
cant DEGs under each comparison design and looked for overlapping genes, to investigate if
the transcriptional profile changes were contributing to the hypersensitivity of A-NO2
- in
mucA22 mutant bacteria when compared to wild type and ΔmucA). The functional annotation
clustering of the gene set was conducted by DAVID to see if any functional pathway was
related with alternative gene expression. If the overlapping genes were also found in the
mucA22 vs. ΔmucA analyses, it indicates that the genes expressed differently should have a
tight interaction with MucA. Among the DEGs, we selected the PPI partners for MucA from
the interactome database. We also searched the STRING database (https://string-db.org) for
predicted MucA interacting partners. The top 20 interactors with high confidence were used
for in our analysis. To investigate if the transcriptional profile changes were contributing to
the hypersensitivity of A-NO2
- in mucA22 comparing to wild type and ΔmucA, we also com-
pared the significant DEGs under each comparison design and looked for overlapping genes.
The Go function enrichment of the gene set was conducted on the overlapping DEGs and the
predicted MucA interactors, in order to see if any functional pathway was related with altered
gene expression.
Identification of anaerobic S-nitrosylated proteins in PA, mucA22 and
ΔmucA strains using the SNOSID technique (SNO Site Identification)
PA PAO1, mucA22 and ΔmucA were grown in L-broth under aerobic conditions at 37˚C for
18 hr. Bacteria were then further diluted 1000-fold in L-broth, pH 6.5 (50 mM potassium phos-
phate) containing 15 mM KNO3 for 24 hr under anaerobic conditions. Bacteria were then
exposed to 15 mM NaNO2 for 1 hr. The cell pellet was lysed with B-PER plus 0.1 mM EDTA
and 0.5 mM PMSF at room temperature for 10 min. Next, identical protein levels were used to
evaluate S-nitrosylation using the “biotin switch” method as described by Jaffrey and Snyder
[105]. Briefly, protein lysates were placed in blocking solution (2.5% SDS and 0.1% metha-
nethiosulfonate, MMTS) prepared in dimethylformamide (DMF) with 9 volumes of HEN
buffer (250 mM HEPES-NaOH pH 7.7, 1 mM EDTA and 0.1 mM neocuproine) in the dark at
50˚C for 20 min with frequent vortex. The excess MMTS was removed by precipitation with 3
volumes of cold acetone. After centrifugation, the protein pelleted was washed with 70% cold
acetone 4 times and then resuspended into HEN buffer containing 1% SDS, 2.5 mg/ml biotin-
HPDP and 200 mM sodium ascorbate. The mixtures were incubated in the dark at 25˚C for 1
hr with intermittent vortex. The biotinylated nitrosothiols proteins were then precipitated
with acetone. Again, after washing 4 times with 70% cold acetone, the protein pelleted was dis-
solved in 0.1X HEN buffer containing 1% SDS and 3 volumes of neutralization buffer (20 mM
HEPES, pH 7.7, 100 mM NaCl, 1 mM EDTA, and 0.5% Triton X-100) was added followed by
50 μl of pre-washed avidin affinity resin. The mixture was then incubated at 4˚C for 18 hr. The
resin was extensively washed 4 times with 1 ml of washing buffer (20 mM HEPES, pH 7.7, 600
mM NaCl, 1 mM EDTA, and 0.5% Triton X-100) and the resin was fully dried via gentle aspi-
ration with a 28-gauge needle. Bound protein was then eluted with 50 μl of elution buffer (20
mM HEPES, pH 7.7, 100 mM NaCl, 1 mM EDTA, 100 mM 2-mercaptoethanol). The samples
were concentrated and desalted using Amicon1 Ultra centrifuge filter devices (3 K) and the
buffer exchanged 2 times with 50 μl of GE Healthcare Life Sciences DeStreak buffer. The
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protein concentration was determined using a Pierce 660 nm protein assay and prepared for
2-dimensional gel electrophoresis. Then, 27 μg of purified protein was loaded onto 7 cm IPG
strips, pH 3–10 NL (non-linear) and subjected to electrophoresis according to a standardized
procedure for the Invitrogen zoom apparatus with no streaking in the first dimension. After
running denaturing polyacrylamide gel electrophoresis (SDS-PAGE) for the second dimen-
sion, proteins were visualized after silver staining. Gel images were compared using Progenesis
SameSpots V3.2 software ((Nonlinear Dynamic, Inc., Durham, NC). The protein spots that
revealed significant differences in pairs between PA and mucA22, PA and ΔmucA, or mucA22
and ΔmucA were then analyzed using matrix-assisted laser desorption ionization-time of flight
(MALDI-TOF) mass spectrometry. The proteins were then identified by searching the Swiss-
Prot PA mass spectrometric database.
Alginate assays
Selected bacteria were grown in L-broth under aerobic conditions for 24 hr at 37˚C with shak-
ing at 250 rpm. The alginate isolation and assay was performed base on the protocol of Ma et.
al., [106] with minor modifications. Briefly, the overnight bacterial cultures were mixed 1:1
ratio with PBS and then centrifugation at 16,000 x g for 10 min. One volume of 2% cetylpyridi-
nium chloride was added to the supernatant to precipitate the alginate. After centrifugation at
the same speed for 5 min, he pelleted was resuspended in 2 volumes of 1 M NaCl and alginate
was precipitated using 2 volumes of cold isopropanol. After centrifugation and air drying, the
alginate pellet was resuspended in 200 μl of saline. Alginate concentration as mg/ml was calcu-
lated using the carbozole assay [107].
Infection of mouse airways and effects of A-NO2
- on bacterial viability
Six-week old male Balb/C mice (8 per cohort) were purchased from Harlan Laboratories, Inc.
Approximately ~5 x 106 of isogenic mucA22 or ΔmucA strains were resuspended in 0.9% saline
containing purified PA alginate at final concentration of 1.1 mg/ml and used 50 μl to inject
into mouse tracheas nonsurgically using a 21-gauge ball-end needle to the back of the tongue
above the tracheal opening as previously described [108]. The successful delivery of bacteria
into the lungs was manifested by a slight gag reflex by the mice exhibited immediately after
instillation followed by a pattern of rapid breathing. After 24 hr of incubation, mouse lungs
were instilled with 25 μl of 15 mM A-NO2- at pH 6.5 (in 0.1 M phosphate buffer) intranasally
twice daily. On the fifth day, the mice were sacrificed, and the viable bacteria from serially
diluted lung homogenates were enumerated.
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S1 Fig. Two independently generated mucA deletions mapped to an identical position on
the PAO1 genome. PAO1 ORFs, PA PAO1 open reading frames; Red boxes indicate the
mucA deletion regions. A. PAO1 ΔmucA (M.J.S. lab), Illumina reads from PAO1 ΔmucA
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S2 Fig. 2-D gel Western blots for SNO proteins in anaerobically grown strains treated with
15 mM A-NO2
-. A. PAO1; B. mucA22; C. ΔmucA. SNO-proteins were separated using Immo-
biline DryStrip pH 3–10 NL (non-linear) gels and then silver stained. SNO-proteins revealing
differences in signal intensity from each set of protein spots were extracted from the gels and
identified by mass spectrometry. The identification of each circled protein is listed in Table 3
with the fold up or down values given.
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